Cannabis use, gender and age of onset of schizophrenia: data from the ÆSOP study

Psychiatry Res. 2014 Mar 30;215(3):528-32. doi: 10.1016/j.psychres.2013.12.038. Epub 2014 Jan 4.

Abstract

An earlier age of onset of schizophrenia has been identified as a poor prognostic indicator. The current study examines the interaction effect of gender and cannabis use on age of onset of schizophrenia and schizoaffective disorder. This research forms part of a two-centre epidemiological study of first-episode psychosis and included individuals with a diagnosis of schizophrenia or schizoaffective disorder and an age of onset between age 16 and 45. Kaplan-Meier curves and Cox proportional hazards regression were used to compare the effects of cannabis use and gender on age of first symptom of schizophrenia. Akaike's information criteria were used to find the model with the best fit to the data. Cannabis users had an earlier age of first symptom than non-users. There was an interaction with gender; the gender difference in age of onset was diminished in cannabis smokers compared with non-cannabis smokers. The model including cannabis use interacting with gender was the most parsimonious model, followed by cannabis use alone. The addition of other illegal drug use did not improve the model. Cannabis use is associated with an earlier age of onset of schizophrenia, and the gender difference in age of onset is reduced among cannabis smokers.

Keywords: First-episode; Onset; Positive symptoms; Psychosis; Substance misuse.

MeSH terms

  • Adolescent
  • Adult
  • Age of Onset*
  • Cannabinoids
  • Cannabis / adverse effects*
  • Female
  • Humans
  • Kaplan-Meier Estimate
  • Male
  • Marijuana Smoking / adverse effects*
  • Middle Aged
  • Proportional Hazards Models
  • Psychotic Disorders / diagnosis*
  • Psychotic Disorders / etiology
  • Psychotic Disorders / psychology
  • Regression Analysis
  • Schizophrenia / diagnosis*
  • Schizophrenia / etiology
  • Sex Factors

Substances

  • Cannabinoids